The “Best Companies to Work for in Asia” award is an annual accolade presented by HR Asia, recognizing companies with exceptional HR policies, attractive benefits, and outstanding workplace environments. This year, the award acknowledged over 600 companies, with hundreds of thousands of employees participating in the survey. MSD Vietnam proudly emerged as a double winner, excelling across stringent evaluation criteria, including employee engagement, recruitment policies, talent development and retention strategies, and initiatives to enhance employee welfare.
Katharina Geppert, Managing Director of MSD Vietnam, expressed her delight: “We are thrilled to have won two awards at this year’s HR Asia Awards. Our people have always been one of our top strategic priorities throughout our nearly three decades of operations in Vietnam. These awards testify to our serious investment in creating a workplace where every employee feels valued, empowered, and enabled to seize development opportunities to elevate themselves. This is a tremendous motivator for us to continue investing in and implementing even better HR policies.”
Katharina Geppert, Managing Director of MSD Vietnam, shares her delight at the company’s double win at the HR Asia Awards.
MSD Vietnam’s HR policies and initiatives are comprehensively designed to nurture employee well-being, foster professional growth, and cultivate a healthy and productive work culture. The company embraces a hybrid working model, empowering employees to balance their work and personal lives, thereby enhancing their quality of life and work efficiency. Each employee is regarded as a talent to be nurtured through a standardized global enterprise leadership competency framework. MSD’s robust training programs and talent development policies ensure employees have access to the latest knowledge and courses offered by leading universities and HR organizations worldwide.
Speaking about the company’s culture, Doan Dinh Binh, HR Director of MSD Vietnam, shared: “We foster a company culture founded on diversity, equity, and harmony – where every employee feels welcomed, valued, and connected. By bringing together a diverse array of talents from various cultural and professional backgrounds, we unite in our shared purpose: to harness the power of advanced science to save and improve lives in Vietnam. In the past 12 months, approximately 40% of our new hires came from outside the pharmaceutical industry. As of July 2024, female employees comprise around 60% of our total workforce, and over 60% of managerial positions are held by women. Currently, we are proud to have a diverse talent pool spanning three generations, with over 80% belonging to the younger Y and Z generations. Diversity is in our company’s DNA.”
Doan Dinh Binh, HR Director of MSD Vietnam, emphasizes the importance of diversity in the company’s talent pool.
These two prestigious awards, coupled with other notable achievements in the preceding month, have marked a significant milestone for MSD Vietnam this year.
Last month in London, the Global Marketing Influencer Awards honored MSD Vietnam’s Minah project with a Bronze Award in the “Best Use of Influencer Marketing Technology” category. Minah, a virtual health expert on Facebook, was created to raise community awareness about the prevention of cancers and serious diseases caused by Human papillomavirus (“HPV”). Persistent infection with high-risk HPV types can lead to cervical, vulvar, vaginal, oropharyngeal, penile, and anal cancers.
The Minah project is a collaborative effort between the Vietnam Preventive Medicine Association, MSD Vietnam, and Ogilvy Health Asia, aiming to educate the community. Minah leverages the strengths of the project partners in technology and data, coupled with deep market insights, to bridge the generational gap and facilitate meaningful conversations within Asian families, addressing sensitive issues for community health improvement.
In July, the company also introduced, in collaboration with the Vietnam Respiratory Society, a broad-coverage vaccine to actively immunize individuals aged 2 years and above against pneumonia and infections caused by streptococcus pneumoniae, covering prevalent serotypes, with no upper age limit.
Earlier, the Ministry of Health approved new indications for MSD’s cancer immunotherapy, bringing the total number of approved indications to 27 (treating 13 different types of tumors), offering hope and treatment opportunities to more patients.
MSD is a global leading biopharmaceutical company, dedicated to discovering and developing innovative health solutions to prevent and treat diseases in people and animals. For over 130 years, MSD has brought hope to humanity through the development of groundbreaking medicines and vaccines. The company fosters a diverse and inclusive global workforce, committed to creating a safer, healthier, and more sustainable future for all individuals and communities.
